BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28333397)

  • 1. Cardiac device implantations in obese patients: Success rates and complications.
    Attanasio P; Lacour P; Ernert A; Pieske B; Haverkamp W; Blaschke F; Dalle Vedove F; Huemer M
    Clin Cardiol; 2017 Apr; 40(4):230-234. PubMed ID: 28333397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ICD implantation in obese and nonobese patients.
    Venkataraman G; Mathur D; Joshi S; Strickberger A
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):481-5. PubMed ID: 24215359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of applying a low-dose radiation fluoroscopy protocol in device implantations.
    Attanasio P; Mirdamadi M; Wielandts JY; Pieske B; Blaschke F; Boldt LH; Jais P; Haverkamp W; Huemer M
    Europace; 2017 Aug; 19(8):1364-1368. PubMed ID: 27702866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Outcomes, and Costs According to Patient Frailty Status for 2.9 Million Cardiac Electronic Device Implantations in the United States.
    Mohamed MO; Sharma PS; Volgman AS; Bhardwaj R; Kwok CS; Rashid M; Barker D; Patwala A; Mamas MA
    Can J Cardiol; 2019 Nov; 35(11):1465-1474. PubMed ID: 31679618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of an ultra-low frame rate and antiscatter grid-less radiation protocol for cardiac device implantations.
    Attanasio P; Schreiber T; Parwani A; Lacour P; Pieske B; Haverkamp W; Blaschke F; Huemer M
    Pacing Clin Electrophysiol; 2017 Dec; 40(12):1380-1383. PubMed ID: 29090490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality After Magnetic Resonance Imaging of the Brain in Patients With Cardiovascular Implantable Devices.
    Padmanabhan D; Jondal ML; Hodge DO; Mehta RA; Acker NG; Dalzell CM; Kapa S; Asirvatham SJ; Cha YM; Felmlee JP; Watson RE; Friedman PA
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005480. PubMed ID: 29321191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.
    Echouffo-Tcheugui JB; Masoudi FA; Bao H; Curtis JP; Heidenreich PA; Fonarow GC
    Eur J Heart Fail; 2019 Sep; 21(9):1093-1102. PubMed ID: 31359595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after elective abdominal aortic aneurysm repair in obese versus nonobese patients.
    Locham S; Rizwan M; Dakour-Aridi H; Faateh M; Nejim B; Malas M
    J Vasc Surg; 2018 Dec; 68(6):1696-1705. PubMed ID: 29887226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity as a Risk Factor for Consideration for Left Ventricular Assist Devices.
    Mohamedali B; Yost G; Bhat G
    J Card Fail; 2015 Oct; 21(10):800-5. PubMed ID: 26093334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroscopy-guided axillary vein access vs cephalic vein access in pacemaker and defibrillator implantation: Randomized clinical trial of efficacy and safety.
    Jiménez-Díaz J; Higuera-Sobrino F; Piqueras-Flores J; Pérez-Díaz P; González-Marín MA
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1588-1593. PubMed ID: 31310038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of body mass index on complications in cardiac implantable electronic device surgery.
    Güzel T; Demir M; Aktan A; Kılıç R; Arslan B; Günlü S; Altıntaş B; Karahan MZ; Özbek M; Aslan B; Arpa A; Coşkun MS; Altunbaş M; Tüzün R; Akgümüş A; Karadeniz M; Aydın S; Güzel H; Aslan SF; Söner S; Taş A; Ertaş F
    Pacing Clin Electrophysiol; 2024 Feb; 47(2):292-299. PubMed ID: 38078545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors, Morbidity, and Costs Associated with Pneumothorax during Electronic Cardiac Device Implantation.
    Kotter J; Lolay G; Charnigo R; Leung S; McKibbin C; Sousa M; Jimenez L; Gurley J; Biase LD; Natale A; Smyth S; Darrat Y; Morales G; Elayi CS
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):985-91. PubMed ID: 27230623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey.
    Tovia-Brodie O; Rav Acha M; Belhassen B; Gasperetti A; Schiavone M; Forleo GB; Guevara-Valdivia ME; Ruiz DV; Lellouche N; Hamon D; Castagno D; Bellettini M; De Ferrari GM; Laredo M; Carvès JB; Ignatiuk B; Pasquetto G; De Filippo P; Malanchini G; Pavri BB; Raphael C; Rivetti L; Mantovan R; Chinitz J; Harding M; Boriani G; Casali E; Wan EY; Biviano A; Macias C; Havranek S; Lazzerini PE; Canu AM; Zardini M; Conte G; Cano Ó; Casella M; Rudic B; Omelchenko A; Mathuria N; Upadhyay GA; Danon A; Schwartz AL; Maury P; Nakahara S; Goldenberg G; Schaerli N; Bereza S; Auricchio A; Glikson M; Michowitz Y
    Heart Rhythm; 2022 Feb; 19(2):206-216. PubMed ID: 34710561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital complications after implantation of cardiac implantable electronic devices: Analysis of a national inpatient database in Japan.
    Shakya S; Matsui H; Fushimi K; Yasunaga H
    J Cardiol; 2017 Nov; 70(5):405-410. PubMed ID: 28434707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of ultrasound-guided vascular access during cardiac implantable device placement.
    Lin J; Adsit G; Barnett A; Tattersall M; Field ME; Wright J
    J Interv Card Electrophysiol; 2017 Oct; 50(1):105-109. PubMed ID: 28752227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes and predictors of 30-day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database.
    Ahmad S; Munir MB; Sharbaugh MS; Althouse AD; Pasupula DK; Saba S
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):456-462. PubMed ID: 29193418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Pocket Infection Postcardiac Device Implantation Using Antibiotic versus Saline Solution for Pocket Irrigation.
    Lakshmanadoss U; Nuanez B; Kutinsky I; Khalid R; Haines DE; Wong WS
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):978-84. PubMed ID: 27440320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and periprocedural management of cardiac implantable electronic devices in patients with carcinoid heart disease.
    Ward RC; Luis SA; Shabtaie SA; Pellikka PA; Connolly HM; Miranda W; Schaff H; Shen WK; Killu AM; Cha YM; Asirvatham SJ; Deshumkh AJ; DeSimone CV
    Heart Rhythm; 2021 Dec; 18(12):2094-2100. PubMed ID: 34428559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.